跳轉至內容
Merck

Use of ethosuximide and valproate in the treatment of epilepsy.

Neurologic clinics (1986-08-01)
S J Wallace
摘要

Ethosuximide is the drug of first choice in absence seizures. Idiosyncratic side effects are rare. Valproate is effective against absence, generalized tonic-colonic, and partial seizures. It is the drug of choice in photosensitive seizures. Valproate is, on the whole, free from unpleasant side effects, but fatal hepatotoxicity and hyperamnionemia have been reported very rarely.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
乙琥胺
Supelco
乙琥胺, Pharmaceutical Secondary Standard; Certified Reference Material
乙琥胺, European Pharmacopoeia (EP) Reference Standard